Duodenal bicarbonate secretion and mucosal protection. Neurohumoral influence and transport mechanisms.
Duodenal mucosal bicarbonate secretion (DMBS) plays an important role in the defence against acid discharged from the stomach. The secretion by duodenum immediately distal to the Brunner's glands area and devoid of pancreatic and biliary secretions, was investigated in vivo in anaesthetized Sprague-Dawley rats and in vitro in mucosae isolated from the American bullfrog. Transport mechanisms were studied in isolated rat duodenal enterocytes and identified by use of digitized microfluorometry and the fluoroprobe BCECF. Cyclic AMP production in enterocytes of villus vs. crypt origin was measured with radioimmunoassay. The benzodiazepines diazepam and Ro 15-1788 stimulated DMBS in the rat when administered intravenously or intracerebroventricularly; however, their stimulatory effect was abolished by bilateral proximal vagotomy, and they had no effect on the secretion by isolated bullfrog mucosa. It is concluded that these benzodiazepines stimulate secretion by acting upon the central nervous system and that their effects are vagally mediated. Dopamine, the catechol-O-methyl-transferase-inhibitor nitecapone, and the dopamine D1 agonist SKF-38393 all stimulated DMBS. The peripherally acting antagonist domperidone while having no influence on basal DMBS did prevent the influences of SKF-38393 and nitecapone. The alpha 1-antagonist prazosin had no such effects and the combined results suggest that DMBS is stimulated via peripheral dopamine D1 receptors. Intravenous, but not central nervous, administration of the muscarinic M1 receptor antagonists pirenzepine and telenzepine effectively stimulated DMBS; however their effectiveness was dependent on intact vagal nerves. Phentolamine, an unselective alpha-adrenergic antagonist, prevented the stimulation by pirenzepine and telenzepine and stimulation by carbachol was abolished by hexamethonium. It is concluded that peripheral nicotinergic and muscarinergic M1 receptors mediate stimulation of DMBS, in part by acting upon peripheral sympathetic ganglia. Whereas dopamine and SKF-38393 caused a time-dependent increase in the accumulation of cyclic AMP in duodenal enterocytes of crypt and villous origin, the D2 agonist quinpirole had an inhibitive influence. Crypt and villus cells differed in their respective time-courses in response to vasoactive intestinal polypeptide. Finally, Cl-/HCO3- exchange, Na+/H+ exchange and NaHCO3 cotransport were identified as membrane acid/base transport mechanisms in isolated duodenal enterocytes.
Säfsten
B
B
Department of Physiology and Medical Biophysics Biomedical Centre, Uppsala, Sweden.
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000494:pharmacology; D000818:Animals; D017920:Antiporters / Q000502:physiology; D001639:Bicarbonates / Q000378:metabolism*; D001692:Biological Transport / Q000502:physiology; D002217:Carbachol / Q000494:pharmacology; D002352:Carrier Proteins / Q000502:physiology; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology; D027963:Chloride-Bicarbonate Antiporters; D000242:Cyclic AMP / Q000378:metabolism; D003592:Cytophotometry; D003975:Diazepam / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D015259:Dopamine Agents / Q000494:pharmacology; D004386:Duodenum / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D004873:Ergolines / Q000494:pharmacology; D005442:Flumazenil / Q000494:pharmacology; D005753:Gastric Mucosa / Q000166:cytology / Q000502:physiology*; D007413:Intestinal Mucosa / Q000166:cytology / Q000502:physiology*; D008297:Male; D008871:Microvilli / Q000737:chemistry / Q000378:metabolism / Q000502:physiology; D010422:Pentanones / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D019257:Quinpirole; D011863:Radioimmunoassay; D011892:Rana catesbeiana; D051381:Rats; D017207:Rats, Sprague-Dawley; D027982:Sodium-Bicarbonate Symporters; D017923:Sodium-Hydrogen Exchangers / Q000502:physiology; D014456:Ulcer / Q000517:prevention & control
D017920:Antiporters; D001639:Bicarbonates; D002352:Carrier Proteins; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D027963:Chloride-Bicarbonate Antiporters; D015259:Dopamine Agents; D004873:Ergolines; D010422:Pentanones; D027982:Sodium-Bicarbonate Symporters; D017923:Sodium-Hydrogen Exchangers; D019257:Quinpirole; D010890:Pirenzepine; D005442:Flumazenil; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D002217:Carbachol; C057364:nitecapone; D000242:Cyclic AMP; D003975:Diazepam; D004298:Dopamine; D010646:Phentolamine